Full-Time

Associate Director Analytical Development Drug Product

Updated on 5/7/2024

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology

Senior

Princeton, NJ, USA

Required Skills
Communications
Requirements
  • M.S. in Chemistry or related field
  • Ph.D. preferred
  • 8 years of experience in analytical development techniques for finished drug products
  • 5 years in a leadership role
  • Experience authoring technical reports and CMC sections for regulatory filings
  • Hands-on experience in analytical chemistry techniques like chromatography, dissolution, and spectroscopic techniques
  • Strong understanding of GMP working environments and regulatory guidance
  • Knowledge of USP and EP
  • Problem-solving abilities
  • Organizational and documentation skills
  • Verbal and written communication skills
  • Ability to manage change in a dynamic environment
  • Ability to negotiate and influence senior leaders
  • Ability to travel up to 20% domestically and internationally
Responsibilities
  • Develop and validate analytical methods for small molecules in various dosage forms
  • Provide oversight of testing at contract service providers
  • Collaborate with testing labs to develop analytical methods
  • Draft and review method validation protocols and reports
  • Draft and approve analytical methods
  • Provide information for CMC section of regulatory documentation
  • Perform laboratory investigations
  • Liaise with formulations, manufacturing, quality, and regulatory counterparts
  • Assist in assessing technical abilities and formal planning activities
  • Review testing sections of process development protocols and reports
  • Define testing requirements
  • Investigate CSP out-of-specification/out-of-trend for scientific soundness
  • Assess CSP laboratory performance
  • Other duties as assigned

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals is dedicated to enhancing lives through groundbreaking therapies for neurological and mental health disorders, including Parkinson’s disease psychosis, Rett syndrome, and schizophrenia. This focus on specific, underserved symptoms such as hallucinations and delusions establishes a distinct competitive edge in the pharmaceutical industry. Employees engage in pivotal, enriching work that not only advances medical science but also directly impacts patient well-being, making it a commendable workplace.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

San Diego, California

Founded

1993

Growth & Insights
Headcount

6 month growth

7%

1 year growth

14%

2 year growth

20%